United States Antimony: Weak Pricing, Stronger Volumes, And A Government Catalyst

United States Antimony is reiterated as Buy with a $10–$11 target as the stock reacts to weak antimony prices and trailing revenue. Despite a 52% drop in realized antimony prices, Q2 volumes rose 26% YoY, and a $245M government contract is ramping up with revenue conversion just beginning—pointing to upside as deliveries accelerate.

Analysis

UAMY is less a pure antimony beta trade than a test of whether a thinly traded critical-mineral name can turn a commodity recovery story into a contracted-revenue story. The volume inflection matters more than the price weakness: if management can keep tonnage rising while the government contract ramps, the market may eventually re-rate this from a spot-exposed miner to a strategic supplier with better visibility. That said, the first derivative still matters — if realized prices keep falling faster than volumes rise, reported growth will stay low-quality and EBITDA will lag the headline.

The second-order winner is downstream users of antimony inputs, not necessarily other miners: lower input costs can support margin for flame-retardant and industrial customers, while UAMY’s weaker pricing may pressure higher-cost fringe producers first. The key question is whether the government contract is recurring and margin-accretive or simply revenue that arrives with heavy working-capital demands. If the contract converts slowly, the stock can look “cheap” on sales while cash burn and inventory build worsen.

Near term, the catalyst path is 1-3 months: quarterly margin, backlog conversion, and any update on delivery cadence. Over 6-18 months, the thesis only works if UAMY proves it can sustain both volume growth and cash conversion; otherwise the stock will revert to being valued on commodity pricing, not strategic optionality. What would falsify the bullish case: another quarter of volume growth paired with flat or lower gross profit dollars, or any delay in contract monetization.

Key Decisions for Investors

• Small starter long UAMY into weakness, but only as a catalyst trade ahead of the next revenue print; size modest given execution risk and thin liquidity.
• If options are liquid, prefer a 3-6 month UAMY call spread over outright shares to express contract-ramp convexity while limiting downside if antimony prices keep deteriorating.
• Do not add until the company shows sequential gross profit dollar expansion, not just higher tonnage; that is the cleanest confirmation that the contract is actually accretive.
• Set a hard risk monitor: if the next update shows revenue growth without margin expansion, treat that as a thesis break and exit rather than averaging down.